Articles related to PARKINSON'S DISEASE (PD)

Actigraphy devices revealed significant improvements in sleep patterns with nighttime levodopa use, despite patients not perceiving these changes subjectively.

Parkinson’s disease is increasingly recognized as a multisystem disorder, with nonmotor symptoms often preceding the classic motor signs by years or even decades.

A phase 3 clinical trial of buntanetap in early Parkinson’s disease patients demonstrated improvements in motor and cognitive functions, particularly in those with longer disease duration and postural instability.

Identifying early symptoms like loss of smell and constipation can lead to a timely diagnosis of Parkinson’s disease, facilitating earlier intervention and potentially slowing disease progression.

An innovative blood test using artificial intelligence has shown the potential to detect Parkinson’s disease up to seven years before symptoms appear, offering new possibilities for early intervention and treatment.

Non-invasive digital health tools, including wearable sensors and tremor-suppressing devices, are emerging as valuable adjuncts to traditional treatments for tremor management, significantly enhancing patient autonomy and quality of life.